Vaccine candidate PF-07307405 (LB6V) demonstrated more than 70% efficacy in preventing Lyme disease in individuals aged five years and above The …
Read more: Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong …
Read more: Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong …